Jian Zhang
John Joyce, Silvia Panigone, and Jian Zhang were appointed to the board of directors of the Company.
Highest-materiality recent filing
IB Acquisition shareholders approve extension to Sept 28, 2026; ~$7.9M redeemed from trust
All three proposals (extension, trust amendment, adjournment) passed with 5,007,821 for, 70,000 against, no abstentions.
GNQ Insilico enters collaboration with Fortune 100 tech firm for AI-driven drug discovery
GNQ Insilico signed a Joint Initiative Agreement with a Fortune 100 global technology company.
IB Acquisition Corp. enters into $500M business combination with GNQ Insilico Inc.
Total arrangement consideration of $500M plus potential revenue and share-price earnouts.
IBAC extends business combination deadline to March 2026; ~$106M redeemed, trust drops to ~$15.8M
Stockholders approved extension from Sept 28, 2025 to March 28, 2026 for initial business combination.
IB Acquisition Corp. closes $115M SPAC IPO; trust funded with $115.575M
Sold 11.5M units at $10/unit (including full over-allotment) for gross proceeds of $115M.
John Joyce, Silvia Panigone, and Jian Zhang were appointed to the board of directors of the Company.
John Joyce, Silvia Panigone, and Jian Zhang were appointed to the board of directors of the Company.
John Joyce, Silvia Panigone, and Jian Zhang were appointed to the board of directors of the Company.
Max materiality 0.85 · Median 0.62 · Most common event other_material